SA VESALE PHARMACEUTICA
The Belgian Vésale Pharma specializes in R&D on probiotic solutions. As a pioneer company, Vésale Pharma dedicates 23% of turnover in R&D every year and works with major Belgian and international Universities or Institutes (e.g., the Pasteur Institute of Lille-France or Texas A&M University-USA). Products are sold in more than 30 countries worldwide through a network of agents and distributors. Vésale holds 6 worldwide patents, including the patent Intelicaps®, a world unique revolutionary technology of probiotics micro-encapsulation.
The two main added values are the Research-based products range with documented strains and the world unique revolutionary technology of probiotics micro-encapsulation called Intelicaps®. Intelicaps® increases dramatically the survival of live probiotics through gastric passage and is in fact an excellent colonic delivery system. This ends in a 1.000 times higher survival and availability of live probiotics compared to conventional lyophilized counterparts.
The actual probiotic products’ portfolio covers several ranges of probiotics representing not less than 12 products for export made up 4 major ranges (Woman Health range, digestive range, children’s range and immunity range). All our products are also marketed under private label in many countries.
Bactimun, new launch in Immunity. Major new publications for Lactogyn in Women’s health Range and Cibalax part of Intestinal health Range.
News products to complete ranges are in development at present.
|Sales markets||Africa; Asia; Australia; Eastern Europe; Middle East; Western Europe|
|Primary business activity||Manufacturer: Finished Food Products|
|Affiliated categories:||Botanical Extracts |Nutrients |Pharmaceutical Ingredients More|